According to our (Global Info Research) latest study, the global Platelet-Rich Plasma Injection market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Platelet-Rich Plasma Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Platelet-Rich Plasma Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Platelet-Rich Plasma Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Platelet-Rich Plasma Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Platelet-Rich Plasma Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Platelet-Rich Plasma Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Platelet-Rich Plasma Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seikagaku Corporation, Zimmer Biomet Holdings, Orlin & Cohen, Dr. Reddy's Laboratories, Chugai Pharmaceutical, Flexion Therapeutics, Sanofi, Relievus, Teva Pharmaceutical Industries, Wright Medical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Platelet-Rich Plasma Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Leukocyte-rich (LR)-PRP
Leukocyte-poor (LP)-PRP
Others
Market segment by Application
Hospital
Clinic
Pharmacy
Major players covered
Seikagaku Corporation
Zimmer Biomet Holdings
Orlin & Cohen
Dr. Reddy's Laboratories
Chugai Pharmaceutical
Flexion Therapeutics
Sanofi
Relievus
Teva Pharmaceutical Industries
Wright Medical Group
Anika Therapeutics
Bioventus
Ferring Pharmaceuticals
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Platelet-Rich Plasma Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Platelet-Rich Plasma Injection, with price, sales quantity, revenue, and global market share of Platelet-Rich Plasma Injection from 2020 to 2025.
Chapter 3, the Platelet-Rich Plasma Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Platelet-Rich Plasma Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Platelet-Rich Plasma Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Platelet-Rich Plasma Injection.
Chapter 14 and 15, to describe Platelet-Rich Plasma Injection sales channel, distributors, customers, research findings and conclusion.
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Platelet-Rich Plasma Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Leukocyte-rich (LR)-PRP
- 1.3.3 Leukocyte-poor (LP)-PRP
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Platelet-Rich Plasma Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Pharmacy
- 1.5 Global Platelet-Rich Plasma Injection Market Size & Forecast
- 1.5.1 Global Platelet-Rich Plasma Injection Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Platelet-Rich Plasma Injection Sales Quantity (2020-2031)
- 1.5.3 Global Platelet-Rich Plasma Injection Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Seikagaku Corporation
- 2.1.1 Seikagaku Corporation Details
- 2.1.2 Seikagaku Corporation Major Business
- 2.1.3 Seikagaku Corporation Platelet-Rich Plasma Injection Product and Services
- 2.1.4 Seikagaku Corporation Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Seikagaku Corporation Recent Developments/Updates
- 2.2 Zimmer Biomet Holdings
- 2.2.1 Zimmer Biomet Holdings Details
- 2.2.2 Zimmer Biomet Holdings Major Business
- 2.2.3 Zimmer Biomet Holdings Platelet-Rich Plasma Injection Product and Services
- 2.2.4 Zimmer Biomet Holdings Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Zimmer Biomet Holdings Recent Developments/Updates
- 2.3 Orlin & Cohen
- 2.3.1 Orlin & Cohen Details
- 2.3.2 Orlin & Cohen Major Business
- 2.3.3 Orlin & Cohen Platelet-Rich Plasma Injection Product and Services
- 2.3.4 Orlin & Cohen Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Orlin & Cohen Recent Developments/Updates
- 2.4 Dr. Reddy's Laboratories
- 2.4.1 Dr. Reddy's Laboratories Details
- 2.4.2 Dr. Reddy's Laboratories Major Business
- 2.4.3 Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Product and Services
- 2.4.4 Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
- 2.5 Chugai Pharmaceutical
- 2.5.1 Chugai Pharmaceutical Details
- 2.5.2 Chugai Pharmaceutical Major Business
- 2.5.3 Chugai Pharmaceutical Platelet-Rich Plasma Injection Product and Services
- 2.5.4 Chugai Pharmaceutical Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Chugai Pharmaceutical Recent Developments/Updates
- 2.6 Flexion Therapeutics
- 2.6.1 Flexion Therapeutics Details
- 2.6.2 Flexion Therapeutics Major Business
- 2.6.3 Flexion Therapeutics Platelet-Rich Plasma Injection Product and Services
- 2.6.4 Flexion Therapeutics Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Flexion Therapeutics Recent Developments/Updates
- 2.7 Sanofi
- 2.7.1 Sanofi Details
- 2.7.2 Sanofi Major Business
- 2.7.3 Sanofi Platelet-Rich Plasma Injection Product and Services
- 2.7.4 Sanofi Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Sanofi Recent Developments/Updates
- 2.8 Relievus
- 2.8.1 Relievus Details
- 2.8.2 Relievus Major Business
- 2.8.3 Relievus Platelet-Rich Plasma Injection Product and Services
- 2.8.4 Relievus Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Relievus Recent Developments/Updates
- 2.9 Teva Pharmaceutical Industries
- 2.9.1 Teva Pharmaceutical Industries Details
- 2.9.2 Teva Pharmaceutical Industries Major Business
- 2.9.3 Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Product and Services
- 2.9.4 Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
- 2.10 Wright Medical Group
- 2.10.1 Wright Medical Group Details
- 2.10.2 Wright Medical Group Major Business
- 2.10.3 Wright Medical Group Platelet-Rich Plasma Injection Product and Services
- 2.10.4 Wright Medical Group Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Wright Medical Group Recent Developments/Updates
- 2.11 Anika Therapeutics
- 2.11.1 Anika Therapeutics Details
- 2.11.2 Anika Therapeutics Major Business
- 2.11.3 Anika Therapeutics Platelet-Rich Plasma Injection Product and Services
- 2.11.4 Anika Therapeutics Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.11.5 Anika Therapeutics Recent Developments/Updates
- 2.12 Bioventus
- 2.12.1 Bioventus Details
- 2.12.2 Bioventus Major Business
- 2.12.3 Bioventus Platelet-Rich Plasma Injection Product and Services
- 2.12.4 Bioventus Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.12.5 Bioventus Recent Developments/Updates
- 2.13 Ferring Pharmaceuticals
- 2.13.1 Ferring Pharmaceuticals Details
- 2.13.2 Ferring Pharmaceuticals Major Business
- 2.13.3 Ferring Pharmaceuticals Platelet-Rich Plasma Injection Product and Services
- 2.13.4 Ferring Pharmaceuticals Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.13.5 Ferring Pharmaceuticals Recent Developments/Updates
- 2.14 Pfizer
- 2.14.1 Pfizer Details
- 2.14.2 Pfizer Major Business
- 2.14.3 Pfizer Platelet-Rich Plasma Injection Product and Services
- 2.14.4 Pfizer Platelet-Rich Plasma Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.14.5 Pfizer Recent Developments/Updates
- 3 Competitive Environment: Platelet-Rich Plasma Injection by Manufacturer
- 3.1 Global Platelet-Rich Plasma Injection Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Platelet-Rich Plasma Injection Revenue by Manufacturer (2020-2025)
- 3.3 Global Platelet-Rich Plasma Injection Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Platelet-Rich Plasma Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Platelet-Rich Plasma Injection Manufacturer Market Share in 2024
- 3.4.3 Top 6 Platelet-Rich Plasma Injection Manufacturer Market Share in 2024
- 3.5 Platelet-Rich Plasma Injection Market: Overall Company Footprint Analysis
- 3.5.1 Platelet-Rich Plasma Injection Market: Region Footprint
- 3.5.2 Platelet-Rich Plasma Injection Market: Company Product Type Footprint
- 3.5.3 Platelet-Rich Plasma Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Platelet-Rich Plasma Injection Market Size by Region
- 4.1.1 Global Platelet-Rich Plasma Injection Sales Quantity by Region (2020-2031)
- 4.1.2 Global Platelet-Rich Plasma Injection Consumption Value by Region (2020-2031)
- 4.1.3 Global Platelet-Rich Plasma Injection Average Price by Region (2020-2031)
- 4.2 North America Platelet-Rich Plasma Injection Consumption Value (2020-2031)
- 4.3 Europe Platelet-Rich Plasma Injection Consumption Value (2020-2031)
- 4.4 Asia-Pacific Platelet-Rich Plasma Injection Consumption Value (2020-2031)
- 4.5 South America Platelet-Rich Plasma Injection Consumption Value (2020-2031)
- 4.6 Middle East & Africa Platelet-Rich Plasma Injection Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Platelet-Rich Plasma Injection Sales Quantity by Type (2020-2031)
- 5.2 Global Platelet-Rich Plasma Injection Consumption Value by Type (2020-2031)
- 5.3 Global Platelet-Rich Plasma Injection Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Platelet-Rich Plasma Injection Sales Quantity by Application (2020-2031)
- 6.2 Global Platelet-Rich Plasma Injection Consumption Value by Application (2020-2031)
- 6.3 Global Platelet-Rich Plasma Injection Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Platelet-Rich Plasma Injection Sales Quantity by Type (2020-2031)
- 7.2 North America Platelet-Rich Plasma Injection Sales Quantity by Application (2020-2031)
- 7.3 North America Platelet-Rich Plasma Injection Market Size by Country
- 7.3.1 North America Platelet-Rich Plasma Injection Sales Quantity by Country (2020-2031)
- 7.3.2 North America Platelet-Rich Plasma Injection Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Platelet-Rich Plasma Injection Sales Quantity by Type (2020-2031)
- 8.2 Europe Platelet-Rich Plasma Injection Sales Quantity by Application (2020-2031)
- 8.3 Europe Platelet-Rich Plasma Injection Market Size by Country
- 8.3.1 Europe Platelet-Rich Plasma Injection Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Platelet-Rich Plasma Injection Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Platelet-Rich Plasma Injection Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Platelet-Rich Plasma Injection Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Platelet-Rich Plasma Injection Market Size by Region
- 9.3.1 Asia-Pacific Platelet-Rich Plasma Injection Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Platelet-Rich Plasma Injection Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Platelet-Rich Plasma Injection Sales Quantity by Type (2020-2031)
- 10.2 South America Platelet-Rich Plasma Injection Sales Quantity by Application (2020-2031)
- 10.3 South America Platelet-Rich Plasma Injection Market Size by Country
- 10.3.1 South America Platelet-Rich Plasma Injection Sales Quantity by Country (2020-2031)
- 10.3.2 South America Platelet-Rich Plasma Injection Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Platelet-Rich Plasma Injection Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Platelet-Rich Plasma Injection Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Platelet-Rich Plasma Injection Market Size by Country
- 11.3.1 Middle East & Africa Platelet-Rich Plasma Injection Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Platelet-Rich Plasma Injection Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Platelet-Rich Plasma Injection Market Drivers
- 12.2 Platelet-Rich Plasma Injection Market Restraints
- 12.3 Platelet-Rich Plasma Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Platelet-Rich Plasma Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Platelet-Rich Plasma Injection
- 13.3 Platelet-Rich Plasma Injection Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Platelet-Rich Plasma Injection Typical Distributors
- 14.3 Platelet-Rich Plasma Injection Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook